Navigation Links
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Date:10/19/2009

EMERYVILLE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, today announced that the company has named Mark Anderson, Ph.D. as chief scientific officer, a new position for the company.

"We are adding Mark to our team at a critical time as our partnerships with Alcon and Galderma gather significant clinical momentum and our already robust internal pipeline continues to expand," said Ron Najafi, Ph.D., chairman and chief executive officer of NovaBay. "Mark's expertise in the field of infectious diseases and proven track record of clinical success, combined with his demonstrated leadership capabilities, make him an excellent addition to our team. We look forward to his contributions as his experience adds great depth and a new dimension to our management team in this strategically important area to the business."

Dr. Anderson's credentials include over 17 years of successfully leading research and development programs. He holds numerous patents, patent applications and publications to his credit. Prior to joining NovaBay, he has held senior positions at Myriad Genetics, Elitra Pharmaceuticals, Pfizer-Agouron and Ligand-Glycomed. Dr. Anderson holds a doctorate from Purdue University, and completed postdoctoral studies in chemical biology at Harvard University.

"It is an honor to be working with this accomplished scientific team," commented Dr. Anderson. "NovaBay's Aganocide® compounds offer the potential to significantly impact the widespread and growing problem of drug resistance to bacterial, viral and fungal infections. I look forward to beginning my work
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections
2. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
3. Alcon Commences Phase 2 Clinical Trial of NovaBays NVC-422 for Viral Conjunctivitis
4. NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
5. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
6. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
7. EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimers Disease Patient
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
10. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
11. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... 25, 2011 The Wound and Hyperbaric ... by the Undersea and Hyperbaric Medical Society (UHMS), the ... that few hospitals and facilities have earned, and identifies ... The super oxygenation offered by hyperbaric treatments can ...
... a privately held medical device company focused on developing ... Aspen™ Spinous Process Fixation System (Aspen) was featured in ... Advanced Spine Techniques (IMAST) in Copenhagen, Denmark, July 13th ... Lanx, commented, "These scientific sessions at IMAST add to ...
Cached Medicine Technology:Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 2Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 3Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST 2Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST 3
(Date:8/28/2015)... ... 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, a ... carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that ... Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected by ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima ... and diagramming network and data center assets and audio-video devices, recently released Visio ... Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro Computer ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest ... Work in Healthcare by Modern Healthcare and will be honored at an awards ... eighth year, the Best Places to Work in Healthcare program recognizes outstanding employers in ...
(Date:8/28/2015)... ... August 28, 2015 , ... CARF International announced ... residential, counseling, day treatment and intensive family based services. , By pursuing and ... and its pursuit of excellence. As a nonprofit charity for more than 50 ...
(Date:8/28/2015)... Phoenix, Arizona (PRWEB) , ... August 28, 2015 ... ... visibility and increased patient loyalty at a low cost. Personalized with practice contact ... new and existing patients. Dental offices can also incorporate Calendars into seasonal mailings, ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
... ... ... Eltman, Eltman & Cooper , a leading credit and collections law firm since 1947, ... 80% of judgments go unpaid. By applying advanced analytics, law enforcement grade investigations and experts ...
... ... service and selfless acts of courage that help make the IMD one of Chicago’s safest ... ... nation’s largest urban medical district, recognized its honored District Security Group (DSG) Members and their ...
... to nearly two-thirds (62.1 percent) of all bankruptci es ... issue of the American Journal of Medicine ... collected prior to the current economic downturn and hence ... 2001 and 2007, the proportion of all bankruptcies attributable ...
... Direction and Collaboration , , BALTIMORE, June 3 ... in Baltimore, MD with the anticipated outcome to set ... epidemic. This conference will for the first time gather ... discuss developments and unanswered questions of appetite control linking ...
... 3 The Orlando Dermatology Aesthetic & Clinical (ODAC) conference ... on January 15-18, 2010 at the ... ODAC educates physicians and medical staff in the latest developments ... management , as well as recent technological advances in ...
... WASHINGTON, June 3 Today, Lung Cancer Alliance ... team guiding consideration of historic legislation that would give the ... products. , , (Logo: ... (D-CT), a senior member of the Senate Health, Labor, Education ...
Cached Medicine News:Health News:Eltman, Eltman & Cooper: The Nation's Leading Judgment Enforcement Firm 2Health News:Eltman, Eltman & Cooper: The Nation's Leading Judgment Enforcement Firm 3Health News:Illinois Medical District Recognizes Officers of its District Security Group 2Health News:Illness, medical bills linked to nearly two-thirds of bankruptcies 2Health News:Illness, medical bills linked to nearly two-thirds of bankruptcies 3Health News:First International Conference on Appetite Control Begins This Week 2Health News:Orlando Dermatology Aesthetic & Clinical (ODAC) Conference Announces Its 2010 Event 2Health News:LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco 2
... NOW Hepatitis B test is a rapid field ... a Hepatitis B infection. This simple, two-step test ... treatment and improved patient outcomes. , ,Intended use: ... in vitro immunodiagnostic test for the detection of ...
... Acrylic is the newest technology available in ... lens combines exceptional material and design properties ... , Biostability , Unique foldable hydrophobic acrylic ... to be biostable , High index ...
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Providing maximum versatility and maneuverability, the Articulator 35 is the only stapler for use in endoscopic and open procures that provides greater access to targeted structures with limited oper...
Medicine Products: